These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24246657)

  • 21. Butyrylcholinesterase activity-biomarker for predicting the outcome in acute cholinesterase inhibitor poisoning--a 30-year retrospective analysis.
    Gazzi EN; Sorodoc V; Petris O; Tarţău L; Dumitrescu G; Sorodoc L; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):971-8. PubMed ID: 25581956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprint of 'Evaluating organophosphate poisoning in human serum with paper'.
    Yen TH; Chen KH; Hsu MY; Fan ST; Huang YF; Chang CL; Wang YP; Cheng CM
    Talanta; 2015 Dec; 145():66-72. PubMed ID: 26459445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organophosphorus poisoning presentating as diabetic ketoacidosis: a real challenge for the endocrinologist.
    Shahid M; Sarfaraz A; Mahar SA; Asghar A; Nakeer R
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):877-8. PubMed ID: 25404455
    [No Abstract]   [Full Text] [Related]  

  • 24. Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorous poisoning.
    Soreq H; Zakut H
    Pharm Res; 1990 Jan; 7(1):1-7. PubMed ID: 2405380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.
    Reiner E; Radić Z; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.
    Kovalevsky A; Blumenthal DK; Cheng X; Taylor P; Radić Z
    Ann N Y Acad Sci; 2016 Aug; 1378(1):41-49. PubMed ID: 27371941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of red blood cell acetylcholinesterase measurement in mechanically ventilated subjects after organophosphate poisoning.
    Moon J; Chun B
    Respir Care; 2014 Sep; 59(9):1360-8. PubMed ID: 24865421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red blood cell acetylcholinesterase and plasma butyrylcholinesterase status: important indicators for the treatment of patients poisoned by organophosphorus compounds.
    Thiermann H; Kehe K; Steinritz D; Mikler J; Hill I; Zilker T; Eyer P; Worek F
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):359-66. PubMed ID: 17913691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Simultaneous cholinergic and intermediate syndromes in organophosphate poisoning].
    Delgado M; Catalán I; Masclans J; Mas A
    Med Intensiva; 2010 Nov; 34(8):573. PubMed ID: 20236732
    [No Abstract]   [Full Text] [Related]  

  • 31. [SIMPLE METHOD FOR HIGHLY SENSITIVE DETECTION OF ORGANIC PHOSPHORUS INHIBITORS OF CHOLINESTERASE AND FOR RAPID DETERMINATION OF PSEUDOCHOLINESTERASE].
    MATOUSEK J; CERMAN J
    Prac Lek; 1964 Jan; 16():13-6. PubMed ID: 14159683
    [No Abstract]   [Full Text] [Related]  

  • 32. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
    Petroianu GA; Arafat K; Schmitt A; Hasan MY
    J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New original in vitro method to assess cholinesterase reactivity in organophosphate poisoning.
    Sorodoc L; Lionte C; Largu E; Petriş O
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):757-63. PubMed ID: 21235118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients.
    Thiermann H; Mast U; Klimmek R; Eyer P; Hibler A; Pfab R; Felgenhauer N; Zilker T
    Hum Exp Toxicol; 1997 Aug; 16(8):473-80. PubMed ID: 9292288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiological aspects of intermediate syndrome in organophosphate poisonings].
    Rafai MA; Boulaajaj FZ; Charra B; Benslama A; Motaouakkil S; Slassi I
    Rev Neurol (Paris); 2007 Apr; 163(4):480-2. PubMed ID: 17452951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
    Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
    Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
    Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
    Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors influencing the efficacy of obidoxime in organophosphate pesticides poisoning.
    Zilker T; Felgenhauer N; Hibler A; Pfab R; Thiermann H; Worek F; Eyer P
    Przegl Lek; 1997; 54(10):662-4. PubMed ID: 9478082
    [No Abstract]   [Full Text] [Related]  

  • 39. The difference in C-reactive protein value between initial and 24 hours follow-up (D-CRP) data as a predictor of mortality in organophosphate poisoned patients.
    Lee JH; Lee YH; Park YH; Kim YH; Hong CK; Cho KW; Hwang SY
    Clin Toxicol (Phila); 2013 Jan; 51(1):29-34. PubMed ID: 23170819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and management of organophosphate poisoning.
    Milby TH
    JAMA; 1971 Jun; 216(13):2131-3. PubMed ID: 4932140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.